Our strategy
Sustainability + Innovation = Growth
Our strategy is to combine leadership in sustainability with market-leading innovation to deliver consistent top and bottom-line growth, with profit growing ahead of sales, ahead of volume. This enables us to help to meet global challenges and capture new opportunities. By doing so, we create lasting value for our stakeholders and pave the way for a more resilient, sustainable future.
2023 Annual Report
15.2 MB
2023 Reporting datapack
Smart science to improve lives™
Sustainability
Innovation
Scale biotechnology
Scaling biotechnology is enabling ingredients to be produced using techniques such as fermentation, significantly improving the sustainability profile of manufacturing processes and raw materials.
Doing the basics brilliantly
Our 'doing the basics brilliantly' programme drives continuous operational improvements, aimed at improving the customer experience and increasing employee productivity by leveraging digital technologies and streamlining processes.
Strengthen to grow consumer care
In Consumer Care we aim to be the most sustainable, responsive supplier of innovative ingredients. We are strengthening the portfolio through continued innovation, developing claims-based ingredients with objective and verifiable performance data provided by our advanced validation techniques. The sustainability profile of our portfolio is a source of competitive advantage and we are further strengthening the portfolio by developing new ingredients with superior sustainability credentials, including bio-based, biodegradable and low-carbon products, with validated claims data.
Expand life sciences
Our strategy in Life Sciences is to empower biologics delivery, enabling the shift to biological active ingredients in pharmaceutical and agricultural markets that will drive structural growth opportunities in the years to come. This move from chemically synthesised to biological active ingredients is already underway in pharmaceutical markets but is in its earlier stages in agricultural markets. We aim to broaden our portfolio of pharma delivery systems and bioprocessing aids through organic investment, technology partnerships and selective bolt-on acquisitions that bring a unique capability to the Group.
Proactive M&A
We look to acquire disruptive technologies and complementary bolt-on acquisitions that we can scale through organic investment in line with our 'buy and build' model. M&A is strategy-led with 'chief scouts' in Consumer Care and Life Sciences working to identify technologies of the future.
Fast grow Asia
By expanding our presence in Asia, we will be able to access high-growth markets that are developing at a faster pace with opportunities across Consumer Care and Life Sciences.
Our markets
We develop and supply innovative high-value ingredients that are typically included at low inclusion levels and offer critical functionality to our customers formulations. We are united by our Purpose of using Smart science to improve lives™, with our ingredients delivering a positive impact in all our markets.
Our approach
Sustainability means doing business the right way, adapting and challenging ourselves to meet business needs, today and in the future.
Smart science
Innovation drives us to achieve our Purpose, from the ingredients we create and how we operate, to the natural, renewable raw materials that we use.